Proteapex Therapeutics
Get Full AccessDescription
- ProteaPex Therapeutics is creating a disease modifying therapeutic technology to treat osteoarthritis (OA) in companion animals, a disease that affects over 20% of dogs and a growing number of cats in the US.Osteoarthritis (OA) is a serious health problem in pets. Yet, the only drugs available are for pain. Unfortunately long-term use of these cause internal bleeding, kidney failure and in extreme cases, death. ProteaPex Therapeutics has developed a novel treatment that is safe, effective and economical. It is an intra-joint peptide injection that reduces the pain and damage caused by OA. In addition, ProteaPex Therapeutics has a broad base of products for treatment of orthopedic, periodontal and wound healing health issues.
-
Headquarters:4170 City Avenue , Philadelphia, Pennsylvania, United States
More -
Phone Number:
-
-
Employees:2
-
Revenue:$1 - 10M
-
Legal Name:Proteapex Therapeutics
-
Proteapex Therapeutics's Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
View Employees
Frequently Asked Questions regarding Proteapex Therapeutics
-
Where are Proteapex Therapeutics's Headquarters?
Proteapex Therapeutics's Headquarters are in 4170 City Avenue ,Philadelphia,Pennsylvania,United States
-
What is Proteapex Therapeutics's official website?
Proteapex Therapeutics's official website is https://www.proteapextherapeutics.com
-
What is Proteapex Therapeutics's Revenue?
Proteapex Therapeutics's revenue is $1 - 10M
-
What is Proteapex Therapeutics's NAICS code?
Proteapex Therapeutics's NAICS code is 541713
-
How many employees are working in Proteapex Therapeutics
Proteapex Therapeutics has 2 employees
-
What is Proteapex Therapeutics's Industry?
Proteapex Therapeutics is in the industry of Biotechnology
-
Who is Proteapex Therapeutics's CEO?
Proteapex Therapeutics's CEO is Jeffrey Boily

